Lead regulatory strategy for oncology drug development programs, ensuring alignment with US and global health authorities.
Plan and manage Clinical Trial Applications, Market Applications, and amendments with high-quality submissions.
Collaborate cross-functionally to integrate evolving regulations and drive process improvements.
Iovance Biotherapeutics is a global leader in developing and delivering tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors, with an FDA-approved treatment for advanced melanoma. The company operates as an end-to-end cell therapy organization with U.S.-based manufacturing, serving thousands of cancer patients worldwide.
Own the commercial assessment of pipeline assets, including market sizing, target product profiles, and competitive analysis.
Drive portfolio prioritization, forecasting, and commercial recommendations to inform Go/No-Go decisions for registrational trials.
Represent Commercial in enterprise forums, operating as the strategic integrator to align stakeholders and drive execution.
Iovance Biotherapeutics is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. The company operates as an end-to-end cell therapy organization with fully owned, centralized U.S.-based manufacturing, serving thousands of cancer patients worldwide each year.
Develop and execute U.S. stakeholder engagement strategies for advocacy and professional societies.
Build relationships with KOLs, patient advocacy groups, and oncology experts.
Lead regional oncology conferences and advocacy events for launch readiness.
Iovance Biotherapeutics is the global leader in developing and delivering tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. The company operates as an end-to-end cell therapy organization with U.S.-based manufacturing, serving cancer patients worldwide.
Partner with the Asset Entrepreneur to anticipate program inflection points and model backup scenarios.
Own program execution end-to-end, operating as the COO of a single-asset biotech.
Translate complex scientific, clinical, and regulatory inputs into clear options for the Board and C-suite.
Enveda is a clinical-stage, AI-enabled biotech discovering medicines from nature four times faster than the industry standard. With over $845M in funding and a $2B valuation, it has three oral medicines in the clinic and is recognized as a top startup employer.
Set and communicate the global commercial strategy and own P&L for the Proleukin business across U.S. and international markets.
Partner with Clinical, Regulatory, Medical Affairs, Sales, Market Access, and Manufacturing to align commercial plans, supply, and compliance.
Lead staffing, talent development, and succession planning while overseeing distribution, revenue forecasts, and risk management.
Iovance Biotherapeutics is the global leader in developing and delivering tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors, with the first FDA-approved one-time treatment for advanced melanoma. The company operates as an end-to-end cell therapy organization, anchored by centralized U.S.-based manufacturing, and fosters a culture of innovation, integrity, and inclusion.
Advance the medical strategy within the assigned territory through fair-balanced, evidence-based scientific exchange and credible partnership with the healthcare community.
Deliver high-quality scientific and clinical presentations on disease states and Iovance products to internal and external audiences, tailoring content to audience needs.
Build and sustain relationships with external experts, collect field medical insights, and support clinical trial site identification and execution.
Iovance Biotherapeutics is a global leader in developing tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. It is an end-to-end cell therapy company with centralized U.S.-based manufacturing, serving thousands of cancer patients worldwide each year.
Lead and develop the West Region Oncology Sales team, driving launch excellence for a personalized mRNA cancer therapy.
Build and execute regional account strategies across complex health systems and oncology practices to achieve sales targets.
Foster a high-performance culture through coaching, compliance, and data-driven decision-making.
Moderna is a biotechnology company pioneering messenger RNA medicines and advancing personalized cancer therapies. It is a high-growth, transformational organization recognized for a bold, relentless, curious, and collaborative culture.